Venus Remedies has leveraged an inspiring two-decade experience to emerge among 50 leading pharmaceutical companies in India. The Company has been ranked 107th in Asia (Source: Bio Spectrum Asia) and among 500 Largest Pharmaceutical Manufacturing Companies in the world (Source: Plimsoll Worldwide Business Intelligence Report).
By the virtue of having selected to specialise through the injectables route in high-growth therapeutic segments like anti-infective, oncology, cardiovascular and neurology, Venus Remedies is among the world’s 10 leading fixed dosage injectables manufacturers.
The result is a presence in 60 countries and covering more than 75 products.
Venus is an Indian company by origin; it is an international company by presence and mindset. The Company is headquartered in Panchkula (India); its three manufacturing units are in Panchkula, Baddi (both India) and Werne (Germany). The Company’s 11 overseas marketing offices include a presence in the US and Germany, among the most demanding pharmaceutical destinations in the world.
Besides, Venus’ manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS. The Company has also been approved by EUROPEAN-GMP, WHO-GMP, Latin American GMP (INVIMA), Ukrainian GMP, Zimbabwe GMP, Uganda GMP, Syrian GMP, Columbian GMP, Kenya GMP, Yemen GMP, Saudi Arabian GMP and Iranian GMP, among others.
Venus is one of the very few R&D-led in the world working on AMR. The Company could foresee the potential of antibiotics fading 10 years back and it is the result of its focused approach that today it has some the SUPER BUG tackling solutions under patent protection. The Company’s research and development center, approved by Department of Scientific and Industrial Research, Government of India (DSIR), is located in Baddi.